|
|
| Model Number |
RRT06060080L |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Obstruction/Occlusion (2422)
|
| Date of Event |
02/24/2014
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
A1 code: no patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.H6: b20 and h3 other code: the medical device remains implanted and therefore couldn't be evaluated.H6 code b13: further additional information was requested from the physician and will be communicated in the next report.H6 code b14: a review of the manufacturing records indicated the lots met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
The following was reported to gore: reportedly on (b)(6), 2014, this patient underwent a procedure for the treatment of an occlusive peripheral arterial disease in which a gore-tex® vascular graft was used as a bypass (femoro-tibial bypass).Reportedly, the whole procedure was uneventful, access was successfully gained, device deployed as intended, catheters were successfully removed and the patency of the device was confirmed at the end of the procedure.The patient received heparin during the procedure.According to reports, on (b)(6), 2014 an adverse event termed " thrombosis of the gore left femoro tibial anterior bypass" was discovered.The relationship was recorded as disease-related and it was recorded that the adverse event required treatment.
|
| |
|
Additional Manufacturer Narrative
|
|
H6: corrected imdrf codes.
|
| |
|
Search Alerts/Recalls
|
|
|